Serotonin, dopamine and norepinephrine transporter mRNAs: Heterogeneity of distribution and response to 'binge' cocaine administration

Molecular Brain Research

Volumn 49, Issue 1-2, 1997, Pages 95-102

  Burchett, Scott A ^a   Bannon, Michael J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Dorsal raphe; Hybridization, in situ; Locus coeruleus; Substantia nigra; Transport; Ventral tegmental area

Indexed keywords

CARRIER PROTEIN; COCAINE; DOPAMINE TRANSPORTER; MESSENGER RNA; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; GENETIC TRANSCRIPTION; IN SITU HYBRIDIZATION; LOCUS CERULEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; VENTRAL TEGMENTUM;

ANIMALS; BRAIN; CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; LOCUS COERULEUS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGAN SPECIFICITY; RAPHE NUCLEI; RATS; RATS, INBRED F344; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBSTANCE-RELATED DISORDERS; SUBSTANTIA NIGRA; SYMPORTERS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0030697883     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00131-9     Document Type: Article

References (43)

1. M.J. Bannon, J.G. Granneman, G. Kapatos, The dopamine transporter: potential involvement in neuropsychiatric disorders, in: F. Bloom, D. Kupfer (Eds.), Psychopharmacology: the Fourth Generation of Progress, Raven, New York, NY, 1995, pp. 179-187.
2. Bannon M.J., Whitty C.J. Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology. 48:1997;969-977.
3. E.L. Barker, R.D. Blakely, Norepinephrine and serotonin transporters: molecular targets of antidepressant action, in: F. Bloom, D. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven, New York, NY, 1995, pp. 321-333.
4. Blanchard V., Raisman-Vozari R., Vyas S., Michel P.A., Javoy-Agid F., Uhl G., Agid Y. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. Mol. Brain Res. 22:1994;29-40.
5. Carroll M.E., Lac S.T., Asencio M., Kragh R. Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Pyschopharmacology. 100:1990;293-300.
6. Carroll M.E., Lac S.T., Marisel A., Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35:1990;237-244.
7. Cerutti C., Pilotte N.S., Uhl G., Kuhar M.J. Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. Mol. Brain Res. 22:1994;132-138.
8. Chiodo L.A. Dopamine-containing neurons in the mammalian central nervous system. Electrophysiology and pharmacology. Neurosci. Biol. Behav. Rev. 12:1988;49-91.
9. Ellinwood E.H., Balster R.L. Rating the behavioral effects of amphetamine. Eur. J. Pharmacol. 28:1974;35-41.
10. Fujita M., Shimada S., Maeno T., Nishimura M., Tohyama M. Cellular localization of serotonin transporter mRNA in the rat brain. Neurosci. Lett. 162:1993;59-62.
11. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science. 251:1991;1580-1586.
12. Goeders N., Smith J.E. Cortical dopaminergic involvement in cocaine reinforcement. Science. 221:1983;773-775.
13. Gonzales C., Chesselet M.-F. The amygdalo-nigral pathway: an anterograde study in the rat using Phaseolus vugaris leucoagglutinin (PHA-L). J. Comp. Neurol. 297:1990;182-200.
14. Hensler J.G., Ferry R.C., Labow D.M., Kovachich G.B., Frazer A. Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus. Synapse. 17:1994;1-15.
15. Jayaraman A., Nishimori T., Dobner P., Uhl G.R. Cholecystokinin and neurotensin mRNAs are differentially expressed in subnuclei of the ventral tegmental area. J. Comp. Neurol. 296:1990;291-302.
16. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
17. Kelly P.H., Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40:1975;45-50.
18. M.M. Kilbey, E.H. Ellinwood, Chronic administration of stimulant drugs: response modification, in: E.H. Ellinwood, M.M. Kilbey (Eds.), Cocaine and Other Stimulants, Plenum, New York, NY, 1976, pp. 409-429.
19. Kuroda Y., Watanabe Y., McEwen B. Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brain. Eur. J. Pharmacol. 268:1994;R3-R5.
20. Leviel V., Faucon Biguet N. In vivo analysis of gene expression in central catecholamine cells. Methods Neurosci. 9:1992;465-479.
21. Lo E.A., Roberts D.C.S. Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology. 101:1990;262-266.
22. Lorang D., Amara S.G., Simerly R.B. Cell-type-specific expression of catecholamine transporters in the rat brain. J. Neurosci. 14:1994;4903-4914.
23. Lowenstein D.H., Massa S.M., Rowbotham M.C., Collins S.D., McKinney H.E., Simon R.P. Acute neurologic and psychiatric complications associated with cocaine abuse. Am. J. Med. 83:1987;84146.
24. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, Australia, 1986.
25. Peris J., Boyson S.J., Cass W.A., Curella P., Dwoskin L.P., Gaynor L., Lin L.-H., Yasuda R.P., Zahniser N.R. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253:1990;38-44.
26. Porrino L.J., Ritz M.C., Goodman N.L., Sharpe L., Kuhar M.J. Differential effects of the pharmacological manipulation of serotonergic system on cocaine and amphetamine self-administration in rats. Life Sci. 45:1989;1529-1535.
27. Post R.M. Cocaine psychosis: a continuum model. Am. J. Psychol. 132:1975;225-231.
28. Pradhan S.N., Battacharyya A.K., Pradhan S. Serotonergic manipulation of the behavioral effects of cocaine in rats. Commun. Psychopharmacol. 2:1978;481-486.
29. Rattray M., Wotherspoon G., Savery D., Baldessari S., Marden C., Priestly J.V., Bendotti C. Chronic D-fenfluramine decreases serotonin transporter messenger RNA expression in the dorsal raphe nucleus. Eur. J. Pharmacol. 268:1994;439-442.
30. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
31. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine-self-administration appears to be mediated by dopamine uptake inhibition. Prog. Neuro-Psychopharmacol. Biol. Psychol. 12:1988;233-239.
32. Ritz M.C., Cone J.E., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure activity study. Life Sci. 46:1990;635-645.
33. Roberts D.C.S., Corcoran M.E., Fibiger H.C. On the role of the ascending catecholamine systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6:1977;615-620.
34. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
35. Sanghera M.K., Manaye K.F., Liang C.L., Iacopino A.M., Bannon M.J., German D.C. Low dopamine transporter mRNA levels in midbrain regions containing calbindin. NeuroReport. 5:1994;1641-1644.
36. Sherer M.A., Kumor K.M., Cone E.J., Jaffe J.H. Suspiciousness induced by four-hour intravenous infusions of cocaine. Arch. Gen. Psychiatry. 45:1988;673-677.
37. Shimada S., Kitayama S., Walther D., Uhl G. Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Mol. Brain Res. 13:1992;359-362.
38. Unterwald E.M., Rubenfeld J.M., Kreek M.J. Repeated cocaine administration upregulates κ and μ, but not δ opioid receptors. NeuroReport. 5:1994;1613-1616.
39. Wakade A.R., Wakade T.D., Poosch M., Bannon M.J. Noradrenaline transport and transporter mRNA of rat chromaffin cells are controlled by dexamethasone and nerve growth factor. J. Physiol. 494.1:1996;67-75.
40. Whitty C.J., Paul M.A., Bannon M.J. Neurokinin receptor mRNA localization in human midbrain dopamine neurons. J. Comp. Neurol. 382:1997;394-400.
41. Whitty C.J., Walker P.D., Goebel M.S., Poosch M.S., Bannon M.J. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience. 64:1995;419-425.
42. Xia Y., Goebel D.J., Kapatos G., Bannon M.J. Quantification of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal. J. Neurochem. 59:1992;1179-1182.
43. N.R. Zahniser, G.A. Gerhardt, W.A. Cass, Chronic cocaine action on the dopamine transporter, in: R.P. Hammer (Ed.), The Neurobiology of Cocaine: Cellular and Molecular Mechanisms, CRC Press, 1995, pp. 181-197.